SHR-A1909

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-A1909, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors [Phase 1]